Miller I, Scheffer IE, Gunning B, Sanchez-Carpintero R, Gil-Nagel A, Perry MS, Saneto RP, Checketts D, Dunayevich E, Knappertz V, GWPCARE2 Study Group.
- Study design
- Randomized trial
- Population / model
- Human
- Published
- 2020-05-01
- Journal
- JAMA neurology
From the author abstract
“Of 198 eligible patients (mean [SD] age, 9.3 [4.4] years; 104 female [52.5%]), 66 were randomized to the CBD10 group, 67 to …”
A short attributed excerpt. Read the full abstract and original paper for methods, results and limitations.
Outcome summaries · provisional
Selected source sets; evidence confidence remains ungraded.
Citation and indexing details
PMID 32119035 · PMC7052786
Publication types: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Topic tags: Epilepsy
Metadata checked 2026-11-04. Study design and model tags follow indexing and explicit abstract terms. Citation counts are not evidence of benefit. An available full text does not by itself permit image reuse.